Policies in Saudi Arabia limit multinational pharma access

09/11/2013 | Gulf Business online (United Arab Emirates)

Multinational pharmaceutical companies are finding it difficult to enter Saudi Arabia, according to a study by Decisions Resources, which cited the nation’s strict policies for registration, pricing and drug distribution as major factors. Meanwhile, the Saudi government has implemented policies to encourage growth of the domestic pharmaceuticals industry, an Alpen Capital report found. Business Monitor International places Saudi Arabia as the largest pharmaceutical market in the Gulf Cooperation Council, where health care spending is projected to triple to $133.19 billion by 2018.

View Full Article in:

Gulf Business online (United Arab Emirates)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
In house Compliance Officer
Confidential
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC